Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julia Maltzman

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Lung Cancer (Amsterdam, Netherlands)|January 30, 2013
Farletuzumab in lung cancerAnish Thomas, Julia Maltzman, Raffit Hassan
Springerplus|August 21, 2013
Folate receptor alpha (FRA) expression in breast cancer: identification of a new molecular subtype and association with triple negative diseaseDaniel J O'Shannessy, Elizabeth B Somers, Julia Maltzman, et al.
Oncotarget|March 11, 2015
Safety and biodistribution of 111In-amatuximab in patients with mesothelin expressing cancers using single photon emission computed tomography-computed tomography (SPECT-CT) imagingLiza Lindenberg, Anish Thomas, Stephen Adler, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Lung Cancer (Amsterdam, Netherlands)|January 30, 2013
Farletuzumab in lung cancerAnish Thomas, Julia Maltzman, Raffit Hassan
Springerplus|August 21, 2013
Folate receptor alpha (FRA) expression in breast cancer: identification of a new molecular subtype and association with triple negative diseaseDaniel J O'Shannessy, Elizabeth B Somers, Julia Maltzman, et al.
Oncotarget|March 11, 2015
Safety and biodistribution of 111In-amatuximab in patients with mesothelin expressing cancers using single photon emission computed tomography-computed tomography (SPECT-CT) imagingLiza Lindenberg, Anish Thomas, Stephen Adler, et al.
Pageof 1